Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Accenture plc (ACN) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, including annual and quarterly financial reports, proxy materials and current reports on significant events. As a New York Stock Exchange‑listed company incorporated in Ireland, Accenture uses these filings to provide detailed information on its financial performance, governance, strategy and material developments.
Accenture’s Form 8‑K current reports frequently furnish earnings releases for quarterly and annual periods, outlining revenues, operating margin, earnings per share, bookings, free cash flow and other key metrics. These 8‑K filings also describe the company’s use of non‑GAAP measures such as free cash flow, local‑currency growth and adjusted results that exclude specified business optimization costs, along with reconciliations to GAAP figures. Other 8‑K filings disclose leadership and organizational changes, including updates to Accenture’s growth model and senior management roles.
The company’s definitive proxy statement (DEF 14A) provides extensive detail on corporate governance, board structure, director nominees, executive compensation programs, share incentive plans and shareholder proposals. It also discusses Accenture’s strategy to be the reinvention partner of choice for clients, its Reinvention Services structure, and multi‑year trends in revenue growth, margins, earnings and cash returned to shareholders.
Through this page, users can access Accenture’s 10‑K annual reports, 10‑Q quarterly reports, 8‑K current reports, proxy statements and related exhibits as they are filed with the SEC’s EDGAR system. Stock Titan enhances these documents with AI‑powered summaries that highlight the main points of lengthy filings, explain non‑GAAP reconciliations, and surface items such as compensation plans and governance proposals. Investors tracking ACN can use these filings to review historical performance, understand management’s reporting practices and monitor material events affecting the company.
Accenture’s Class A ordinary shares are being prepared for sale under Rule 144 by Julie Sweet. The notice covers 5,500 Class A ordinary shares, to be sold through UBS Financial Services Inc. on the NYSE, with an aggregate market value listed as 1,371,920.00. These shares were acquired as a stock award from the issuer on 02/01/2026.
The filing also discloses prior sales by Julie Sweet over the past three months: 5,917 Class A ordinary shares sold on 11/05/2025 for gross proceeds of 1,459,276.57, and 1,694 shares sold on 01/14/2026 for 488,380.20. Shares outstanding are reported as 660,432,542 Class A ordinary shares.
Accenture plc director Paula A. Price reported an equity award of 1,454 Class A ordinary shares on January 28, 2026. The filing shows these were granted as restricted share units under the Accenture plc Amended and Restated 2010 Share Incentive Plan at a price of $0 per share.
Following this grant, Price directly beneficially owns 8,822 Class A ordinary shares. This transaction reflects equity-based compensation rather than an open-market purchase or sale.
Accenture plc director Jennifer Nason received an equity grant in the form of restricted share units. On 01/28/2026 she was awarded 914 Class A ordinary shares at a price of $0 per share under the Accenture plc Amended and Restated 2010 Share Incentive Plan.
Following this grant, she directly beneficially owns 1,538 Class A ordinary shares. Restricted share units typically vest over time, aligning director compensation with long-term company performance rather than immediate cash pay.
Accenture plc director Venkata S. M. Renduchintala reported a stock-based award from the company. On 01/28/2026, he received 914 Class A ordinary shares at a price of $0 per share, recorded as an acquisition.
The filing explains this represents a grant of restricted share units under the Accenture plc Amended and Restated 2010 Share Incentive Plan. Following this grant, he beneficially owned 4,622 Class A ordinary shares in total, held directly.
Accenture plc director Masahiko Uotani received an equity grant in the form of restricted share units. On 01/28/2026, he was awarded 914 Class A ordinary shares at a price of $0 per share, representing a stock-based compensation grant under the Accenture plc Amended and Restated 2010 Share Incentive Plan. Following this grant, he beneficially owns 1,538 Class A ordinary shares directly.
Accenture plc director Tracey Thomas Travis reported receiving 1,527 Class A ordinary shares on January 28, 2026, coded as an acquisition at a price of $0 per share. According to the footnote, this represents a grant of restricted share units under the Accenture plc Amended and Restated 2010 Share Incentive Plan. Following this award, her directly held stake increased to 10,107 Class A shares.
Accenture director Nancy McKinstry received an award of 1,212 restricted share units representing Class A ordinary shares on January 28, 2026 under the Accenture plc Amended and Restated 2010 Share Incentive Plan. The units were granted at a stated price of $0 per share, reflecting an equity incentive rather than an open-market purchase.
Following this grant, McKinstry directly beneficially owns 8,478 Class A ordinary shares. This filing records the equity compensation awarded to a board member and updates her reported ownership position in the company.
Accenture plc director Arun Sarin received an equity grant of 1,344 Class A ordinary shares on January 28, 2026. The award was made at a price of $0 per share as restricted share units under the Accenture plc Amended and Restated 2010 Share Incentive Plan.
Following this grant, Sarin beneficially owns 9,822 Class A ordinary shares in direct form.
Accenture plc director Martin Brudermueller received an equity grant of 914 Class A share-based units on January 28, 2026. The filing shows these as acquired at a price of $0. Following this grant, he beneficially owns 2,048 Class A ordinary shares in a direct ownership capacity.
The 914 units are described as restricted share units awarded under the Accenture plc Amended and Restated 2010 Share Incentive Plan, indicating they are part of the company’s standard long-term incentive compensation for directors.
Accenture plc director Alan C. Jope received a grant of 1,491 Class A ordinary shares on January 28, 2026, reported at a price of $0 per share.
The filing notes this represents restricted share units awarded under Accenture’s Amended and Restated 2010 Share Incentive Plan. After this grant, Jope beneficially owns 3,476 Class A ordinary shares directly.